Aradhana Sarin
President bij ACHILLION PHARMACEUTICALS, INC.
Vermogen: 10 M $ op 29-02-2024
Profiel
Dr. Aradhana Sarin is President & Directeur bij Achillion Pharmaceuticals, Inc. en Chief Financial Officer & Executive Vice President bij Alexion Pharmaceuticals, Inc. Hij zit in de Raad van Bestuur van Achillion Pharmaceuticals, Inc. Dr. Sarin was voorheen werkzaam als Onafhankelijk Bestuurder bij OraSure Technologies, Inc., een MD-Healthcare Corporate & Investment Banking bij Citizens, Inc. (Austin, Texas), en als Managing Director-Healthcare Investment Banking bij UBS AG. Hij behaalde zijn MBA aan de Stanford Graduate School of Business.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ASTRAZENECA PLC
0.01% | 31-12-2023 | 82 514 ( 0.01% ) | 10 M $ | 29-02-2024 |
Laatste nieuws over Aradhana Sarin
Actieve functies van Aradhana Sarin
Bedrijven | Functie | Begin |
---|---|---|
ACHILLION PHARMACEUTICALS, INC. | President | 28-01-2020 |
ASTRAZENECA PLC | Director of Finance/CFO | 01-08-2021 |
ANHEUSER-BUSCH INBEV SA/NV | Director/Board Member | 26-04-2023 |
Eerdere bekende functies van Aradhana Sarin
Bedrijven | Functie | Einde |
---|---|---|
CITIZENS, INC. | Corporate Officer/Principal | 01-10-2017 |
UBS | Corporate Officer/Principal | - |
ALEXION PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
ORASURE TECHNOLOGIES, INC. | Director/Board Member | - |
Opleiding van Aradhana Sarin
University of Delhi | Doctorate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
CITIZENS, INC. | Finance |
ASTRAZENECA PLC | Health Technology |
ORASURE TECHNOLOGIES, INC. | Health Technology |
ANHEUSER-BUSCH INBEV SA/NV | Consumer Non-Durables |
Bedrijven in privébezit | 3 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
UBS AG
UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |